241 related articles for article (PubMed ID: 25857595)
1. Association Between Colchicine and Risk of Diabetes Among the Veterans Affairs Population With Gout.
Wang L; Sawhney M; Zhao Y; Carpio GR; Fonseca V; Shi L
Clin Ther; 2015 Jun; 37(6):1206-15. PubMed ID: 25857595
[TBL] [Abstract][Full Text] [Related]
2. Colchicine Significantly Reduces Incident Cancer in Gout Male Patients: A 12-Year Cohort Study.
Kuo MC; Chang SJ; Hsieh MC
Medicine (Baltimore); 2015 Dec; 94(50):e1570. PubMed ID: 26683907
[TBL] [Abstract][Full Text] [Related]
3. Allopurinol use and type 2 diabetes incidence among patients with gout: A VA retrospective cohort study.
Slobodnick A; Toprover M; Greenberg J; Crittenden DB; Pike VC; Qian Y; Zhong H; Pillinger MH
Medicine (Baltimore); 2020 Aug; 99(35):e21675. PubMed ID: 32871882
[TBL] [Abstract][Full Text] [Related]
4. Colchicine Use and Incident Coronary Artery Disease in Male Patients With Gout.
Shah B; Toprover M; Crittenden DB; Jeurling S; Pike VC; Krasnokutsky S; Xia Y; Fisher MC; Slobodnick A; Tenner CT; Katz SD; Pillinger MH
Can J Cardiol; 2020 Nov; 36(11):1722-1728. PubMed ID: 32454073
[TBL] [Abstract][Full Text] [Related]
5. Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population.
Kesselheim AS; Franklin JM; Kim SC; Seeger JD; Solomon DH
J Gen Intern Med; 2015 Nov; 30(11):1633-8. PubMed ID: 25855479
[TBL] [Abstract][Full Text] [Related]
6. Allopurinol Dose Escalation and Mortality Among Patients With Gout: A National Propensity-Matched Cohort Study.
Coburn BW; Michaud K; Bergman DA; Mikuls TR
Arthritis Rheumatol; 2018 Aug; 70(8):1298-1307. PubMed ID: 29513934
[TBL] [Abstract][Full Text] [Related]
7. Quality of care for gout in the US needs improvement.
Singh JA; Hodges JS; Toscano JP; Asch SM
Arthritis Rheum; 2007 Jun; 57(5):822-9. PubMed ID: 17530682
[TBL] [Abstract][Full Text] [Related]
8. Association between colchicine use and the risk of dementia among patients with gout: A nationwide retrospective cohort study.
Chen PY; Tseng CC; Lee YT; Yip HT; Chang R; Wei JC
Int J Rheum Dis; 2024 May; 27(5):e15162. PubMed ID: 38720421
[TBL] [Abstract][Full Text] [Related]
9. Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study.
Chuang JP; Lee JC; Leu TH; Hidajah AC; Chang YH; Li CY
BMJ Open; 2019 Oct; 9(10):e028892. PubMed ID: 31601586
[TBL] [Abstract][Full Text] [Related]
10. Gout after living kidney donation: a matched cohort study.
Lam NN; McArthur E; Kim SJ; Prasad GV; Lentine KL; Reese PP; Kasiske BL; Lok CE; Feldman LS; Garg AX; ;
Am J Kidney Dis; 2015 Jun; 65(6):925-32. PubMed ID: 25818677
[TBL] [Abstract][Full Text] [Related]
11. Gout can increase the risk of periodontal disease in Taiwan.
Chen HH; Ho CW; Hsieh MC; Chen CC; Hsu SP; Lin CL; Kao CH
Postgrad Med; 2020 Aug; 132(6):521-525. PubMed ID: 32298158
[No Abstract] [Full Text] [Related]
12. Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.
Crittenden DB; Lehmann RA; Schneck L; Keenan RT; Shah B; Greenberg JD; Cronstein BN; Sedlis SP; Pillinger MH
J Rheumatol; 2012 Jul; 39(7):1458-64. PubMed ID: 22660810
[TBL] [Abstract][Full Text] [Related]
13. Opportunities for improving medication use and monitoring in gout.
Singh JA; Hodges JS; Asch SM
Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
[TBL] [Abstract][Full Text] [Related]
14. Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study.
Shih HJ; Kao MC; Tsai PS; Fan YC; Huang CJ
Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):328-333. PubMed ID: 28398294
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the association between colchicine therapy and serious adverse events.
Todd BA; Billups SJ; Delate T; Canty KE; Kauffman AB; Rawlings JE; Wagner TM
Pharmacotherapy; 2012 Nov; 32(11):974-80. PubMed ID: 23019065
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data.
Singh JA; Cleveland JD
Ann Rheum Dis; 2020 Apr; 79(4):529-535. PubMed ID: 32024648
[TBL] [Abstract][Full Text] [Related]
17. Real-world treatment patterns of gout patients treated with colchicine or other common treatments for gout in acute care settings: a retrospective chart review study.
Shiozawa A; Cloutier M; Heroux J; Guerin A; Wu EQ; Jackson R
Curr Med Res Opin; 2015 Aug; 31(8):1611-20. PubMed ID: 26086788
[TBL] [Abstract][Full Text] [Related]
18. Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims.
Solomon DH; Liu CC; Kuo IH; Zak A; Kim SC
Ann Rheum Dis; 2016 Sep; 75(9):1674-9. PubMed ID: 26582823
[TBL] [Abstract][Full Text] [Related]
19. Evaluating appropriate use of prophylactic colchicine for gout flare prevention.
George M; Pullman-Mooar S; Hussain F; Schumacher HR
Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1258-62. PubMed ID: 24376081
[TBL] [Abstract][Full Text] [Related]
20. Risk of incident diabetes in patients with gout: a cohort study.
Kim SC; Liu J; Solomon DH
Arthritis Rheumatol; 2015 Jan; 67(1):273-80. PubMed ID: 25332119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]